Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02807636
Title	The Effect of Atezolizumab in Combination With Gemcitabine/Carboplatin and Gemcitabine/Carboplatin Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-based Therapy
Acronym	IMvigor130
Recruitment	Completed
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	Hoffmann-La Roche
Indications	bladder urothelial carcinoma renal pelvis transitional cell carcinoma ureter transitional cell carcinoma urethra transitional cell carcinoma transitional cell carcinoma
Therapies	Atezolizumab + Carboplatin + Gemcitabine Carboplatin + Gemcitabine
Age Groups:	adult
Covered Countries	USA \| TUR \| SVN \| ROU \| POL \| NLD \| ITA \| ISR \| GRC \| GBR \| FIN \| EST \| ESP \| CZE \| CAN \| BRA \| BEL \| AUS